CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine.
Open Access
- 19 July 1994
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 91 (15) , 7207-7211
- https://doi.org/10.1073/pnas.91.15.7207
Abstract
Following natural and experimental infection by simian immunodeficiency virus SIVagm of African green monkeys (AGMs), the natural host, there is no evidence for the development of an immunodeficiency. Within the framework of our studies on human immunodeficiency virus (HIV)/SIV pathogenesis, we investigated the influence of CD8 T lymphocytes on SIVagm replication in AGM CD4 T lymphocytes in vitro. The following observations were made: (i) Peripheral blood mononuclear cells from both seronegative and seropositive AGMs contained only a low proportion (i.e., 10%) of CD4+ lymphocytes, whereas a high proportion (80%) of CD8+ cells was detected. Even after persistent SIVagm infection, CD4 T lymphocytes do not decrease in number. (ii) The target of in vitro infection of peripheral blood cells is the CD4+ mononuclear cell (T lymphocytes, monocytes) and SIVagm infects by binding to the CD4 molecule. (iii) In both naturally and experimentally SIVagm-infected AGMs the CD4+ T cells and monocytes, but not the CD8+ T cells, harbor DNA provirus. (iv) Virus reisolation and virus replication of SIVagm in CD4 T lymphocytes from seropositive AGMs is suppressed in the presence of autologous CD8 T lymphocytes or a soluble factor produced by these cells. Taken together, one possible reason for the apathogenicity of the SIVagm infection in AGMs may be the suppression of virus replication by a soluble, yet unidentified factor secreted by CD8 lymphocytes quantitatively dominating among peripheral blood cell populations. We have tentatively termed this factor "immunodeficiency virus-suppressing lymphokine." In addition, we show that immunodeficiency virus-suppressing lymphokine from AGMs is able to suppress HIV-1 replication in human CD4+ T cells.Keywords
This publication has 23 references indexed in Scilit:
- Vaccine Protection Against SIVmac Infection by High- But Not Low-Dose Whole Inactivated Virus ImmunogenJAIDS Journal of Acquired Immune Deficiency Syndromes, 1992
- Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanismJournal of Virology, 1991
- CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency virusesCellular Immunology, 1991
- Development of vivo of genetic variability of simian immunodeficiency virus.Proceedings of the National Academy of Sciences, 1991
- Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzeesCellular Immunology, 1991
- Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes.The Journal of Immunology, 1988
- The Human Immunodeficiency Virus: Infectivity and Mechanisms of PathogenesisScience, 1988
- Isolation of simian immunodeficiency virus from african green monkeys and seroepidemiologic survey of the virus in various non‐human primatesInternational Journal of Cancer, 1988
- CD8 + Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus ReplicationScience, 1986
- Functional analysis of monkey lymphocyte subsets defined by OKT4 and OKT8 monoclonal antibodiesCellular Immunology, 1983